Clinical Trial Update: Bryostatin 1 in Treating Patients With Myelodysplastic Syndrome [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update indicating completion of bryostatin 1 evaluation in patients with myelodysplastic syndromes (also associated with leukemia).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• Bryostatin-1 (bryostatin-1)

Snippet

Sponsor: Barbara Ann Karmanos Cancer Institute | Conditions: Leukemia, Myelodysplastic Syndromes | Phase 2 | Status: COMPLETED